Latin American Generic Drug Market Faces Regulatory Hurdles, Projected to Reach $14.6 Billion by 2025

Latin America’s generic drug market faces significant regulatory obstacles, hindering the availability of affordable medicines. A recent report indicates that the market is projected to reach $14.6 billion by 2025, but complex regulations, inconsistent enforcement, and lack of transparency impede manufacturers. The report highlights several challenges that generic drug manufacturers encounter in the region. These include navigating intricate regulatory frameworks, dealing with inconsistent enforcement of existing regulations, and facing a general lack of transparency in the approval processes. These hurdles affect patients, governments, and the broader pharmaceutical industry operating in Latin America. The full report can be found at https://www.drugpatentwatch.com/blog/regulatory-challenges-in-the-latin-american-generic-drug-market/.

Newsflash | Powered by GeneOnline AI
Date: April 15, 2025

Related posts:

AACR 2022: Stand Up to Cancer, Standing up to Treatment Oricell Closes $45M Series B1 Financing to Expand Development of Key Products DrugPatentWatch Article: Generic Drug Success Hinges on High-Value Product Selection and Strong Commercial Teams Medical Affairs’ Data Expertise Enhances Marketing, Sales Strategies for Improved HCP Engagement

Author

Mark Chiang

紐約 NYU Computer Science 碩士 紐澤西 UMDNJ Biomedical Informatics 博士 中研院博士後 台灣大學博士後